Risperidone mesylate is used as a serotonin 5-HT2 receptor blocker, a P-glycoprotein inhibitor, and a potent dopamine D2 receptor antagonist; it modulates cytokine release in dendritic cells by dose-dependently inhibiting IL-12 release and enhancing IL-10 production, and at high doses, it can induce TNF-α release from mature dendritic cells.